Evaluate Pharmacokinetics and Safety of Slow Release DHEA (DHEA)
Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA
Sponsor: Indiana University
This PHASE1/PHASE2 trial investigates Asthma and Genotype and is currently completed. Indiana University leads this study, which shows 14 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Aug 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Jun 2025 — Aug 2025 [monthly]
Completed PHASE1/PHASE2
Status: Recruiting → Completed
-
May 2025 — Jun 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jan 2025 — May 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Recruiting PHASE1/PHASE2
▶ Show 9 earlier versions
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2024 — May 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2023 — Mar 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2023 — Oct 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2023 — Aug 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2023 — Jul 2023 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana University
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .